NHI - Company ID 0000877860
The table below shows NATIONAL HEALTH INVESTORS INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $115.13M | $89.85M | $90.66M | $89.30M | $82.94M | $84.97M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
NATIONAL HEALTH INVESTORS INC reported annual revenue of $375.63M for fiscal year 2025. That is up 12.1% from $335.18M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $248.46M (FY 2016) to $375.63M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $7.85M |
| $6.31M |
| $6.13M |
| $6.83M |
| $4.81M |
| $4.87M |
| Operating income | - | - | - | - | - | - |
| Income tax | - | - | - | - | - | - |
| Net income | $40.10M | $32.86M | $36.99M | $34.16M | $28.54M | $35.26M |
| EPS (diluted) | $0.82 | $0.69 | $0.79 | $0.74 | $0.65 | $0.81 |